XENETIC BIOSCIENCES, INC. Investment Income, Interest
XENETIC BIOSCIENCES, INC. (XBIO) reported Investment Income, Interest of $42.07 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- XENETIC BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-06-30 was $42.07K, a 22.89% increase year-over-year.
- XENETIC BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-03-31 was $45.76K, a 16.75% increase year-over-year.
- XENETIC BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-06-30 was $34.23K.
- XENETIC BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-03-31 was $39.19K.
- XENETIC BIOSCIENCES, INC. investment income, interest for fiscal 2014 was $18.96K, a 45.61% decline from fiscal 2013.
- XENETIC BIOSCIENCES, INC. investment income, interest for fiscal 2013 was $34.85K, a 48.50% decline from fiscal 2012.
- XENETIC BIOSCIENCES, INC. investment income, interest for fiscal 2012 was $67.67K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $42.07K 10-Q · filed 2026-08-06 | $87.82K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $45.76K 10-Q · filed 2026-05-12 | |||
| 2025-06-30 | $34.23K 10-Q · filed 2026-08-06 | $73.42K 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $39.19K 10-Q · filed 2026-05-12 | |||
| 2015-09-30 | $67.00 10-Q · filed 2015-11-16 | $981.00 derived: sum of 2 quarters · filed 2015-11-16 | $1.16K 10-Q · filed 2015-11-16 | $8.15K derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-06-30 | $914.00 10-Q · filed 2015-08-19 | $1.09K 10-Q · filed 2015-08-19 | $8.09K derived: sum of 3 quarters · filed 2015-08-19 | $8.30K derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-03-31 | $174.00 10-Q · filed 2015-05-20 | $7.17K derived: sum of 2 quarters · filed 2015-05-20 | $7.39K derived: sum of 3 quarters · filed 2015-11-16 | $18.09K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $7.22K derived: sum of 2 quarters · filed 2015-11-16 | $17.91K derived: sum of 3 quarters · filed 2015-11-16 | $18.96K 10-K · filed 2015-04-15 |
| 2014-09-30 | $218.00 10-Q · filed 2015-11-16 | $10.92K derived: sum of 2 quarters · filed 2015-11-16 | $11.96K 10-Q · filed 2015-11-16 | $18.89K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | $10.70K 10-Q · filed 2015-08-19 | $11.74K 10-Q · filed 2015-08-19 | $18.67K derived: sum of 3 quarters · filed 2015-08-19 | $26.42K derived: sum of 4 quarters · filed 2015-08-19 |
| 2014-03-31 | $1.04K 10-Q · filed 2015-05-20 | $7.97K derived: sum of 2 quarters · filed 2015-07-20 | $15.72K derived: sum of 3 quarters · filed 2015-07-20 | $25.18K derived: sum of 4 quarters · filed 2015-07-20 |
| 2013-12-31 | $6.93K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20 | $14.67K derived: sum of 2 quarters · filed 2015-07-20 | $24.14K derived: sum of 3 quarters · filed 2015-07-20 | $34.85K 10-K · filed 2015-07-20 |
| 2013-09-30 | $7.74K 10-Q · filed 2014-11-14 | $17.21K derived: sum of 2 quarters · filed 2014-11-14 | $27.92K 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $9.46K 10-Q · filed 2014-08-14 | $20.18K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $10.72K 10-Q · filed 2014-05-20 | |||
| 2012-12-31 | $67.67K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |